RELMADA THERAPEUTICS, INC. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Relmada Therapeutics, Inc. on January 13, 2016. The report discloses a scheduled presentation by company officers to the investment community on the same date. The company is incorporated in Nevada and maintains its principal executive offices in New York, NY.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This document serves as a disclosure of an upcoming event rather than a financial statement.
Material Changes
No material changes to financial results or operations are reported in this filing. The primary event is the dissemination of an investor presentation.
Guidance, Outlook, and Risks
- Investor Presentation: A corporate presentation (Exhibit 99.1) was furnished to the market, containing forward-looking statements regarding anticipated clinical and regulatory development, cash position, cash flows, and business strategies.
- Forward-Looking Statements: The company explicitly states that these projections are based on current assumptions and involve significant risks and uncertainties. Actual results may differ materially due to competitive dynamics, regulatory developments, and economic circumstances.
- Risk Factors: Investors are directed to the "Risk Factors" sections of the Annual Report on Form 10-K (filed September 2015) and Quarterly Reports on Form 10-Q (filed February, May, and November 2015) for a detailed understanding of inherent business risks.
- Legal Status: The information in this Item 7.01 and the attached presentation is "furnished" and not "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, nor is it incorporated by reference into other filings.
Key Facts for Investor Verification
- Verify the content of the investor presentation attached as Exhibit 99.1 for specific details on clinical trials and cash runway.
- Review the Form 10-K filed in September 2015 and Form 10-Qs from 2015 for the most recent audited financial data and comprehensive risk factors.
- Confirm the company's current cash position and burn rate through subsequent filings, as this 8-K does not contain updated financial figures.